New anabolic therapies for osteoporosis.

about

Sarcoidosis: a review for the internist.Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment.Osteoporosis: Current Concepts

P2860

Q47665654-82270C6F-C6AF-4A47-AD12-D13936FE58B2 Q48166426-8DF99DCD-AABC-42AC-B400-06DC10C4A166 Q56379389-1133050F-99B0-4866-9D43-214C6F29ACA8

P2860

New anabolic therapies for osteoporosis.

Item

http://www.wikidata.org/entity/Q38646406

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

New anabolic therapies for osteoporosis.

@en

type

Item

label

New anabolic therapies for osteoporosis.

@en

prefLabel

New anabolic therapies for osteoporosis.

@en

P1476

New anabolic therapies for osteoporosis.

@en

P2093

Jessica Pepe

http://www.w3.org/2001/XMLSchema#string

Marco Occhiuto

http://www.w3.org/2001/XMLSchema#string

P2860

Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Vitamin d and its relationship with obesity and muscle.

Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women

Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis.

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.

P2888

s11739-017-1719-4

P304

915-921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11739-017-1719-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cristiana Cipriani

Salvatore Minisola

P577

2017-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28780668

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

New anabolic therapies for osteoporosis.

about

P2860

P2860

New anabolic therapies for osteoporosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921